Melissa McGivney, PharmD, FAPhA, FCCP, joins Over the Counter to celebrate American Pharmacists Month through exploring her organization's role in honoring pharmacists during October as well as the incredible progress the profession has made in recent years.

Brian Smith, PharmD, joins Over the Counter to explore current GLP-1 developments in the marketplace and how this therapy class is revolutionizing the way health care leaders approach medication adherence.

Jennifer Hammons, PharmD, DrPH, joins Over the Counter to discuss her experience as a pharmacist in Appalachia and why rural pharmacies across the country serve as essential public health resources.

Chad Worz, PharmD, BCGP, FASCP, joins Over the Counter to discuss the current status of the Main Street Pharmacy Access Act and what its signing could mean for the future of community pharmacy.

Vanessa Slowey joins Over the Counter to explore the growing emergence of AI, automation, and pharmacy technology, providing a nuanced discussion surrounding the future of pharmacist-led care.

Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, join Over the Counter to discuss ongoing developments regarding change in federal vaccine guidance and its impact on measles outbreaks across the US.

Kenzie Hohman, PharmD, and Scott Stoll join Over the Counter to discuss the power of pharmacy advocacy in driving the profession forward and ensuring business sustainability in the future.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, from Harps Food Stores, join Over the Counter to discuss the pharmacist's prescribing authority, real-world proof of why it must expand, and the focus on putting patients back at the center of care.

Rick Couldry, MS/HSPA, joins Over the Counter to discuss the industry's push to cloud-based pharmacy software and how this digital transformation is revolutionizing pharmacy practice and patient safety in real time.

Rae McMahan joins Over the Counter to discuss recent regulatory action involving CVS Caremark and the Federal Trade Commission, exploring what the collection of PBM reform efforts means for the greater pharmacy industry moving forward.